Head-to-head · Value Score
Found vs Layla
Two GLP-1 deals, scored on the same six factors. Found lands a Value Score of 78, Layla a 74. Here's who gives you the honest lower price — and where each one bites back.
Found
#62 · Grade B- · Fair Price
Est. first month
$289/mo cash month-to-month · $169/mo on a 12-month prepay
Save ~93% vs brand-nameLayla
#146 · Grade C+ · Watch List
Est. first month
From $199/mo (all doses, compounded)
Save ~85% vs brand-nameThe verdict
Found takes it on Value Score, 78 to 74 — an est. $289/mo cash month-to-month · $169/mo on a 12-month prepay first month, though we flag its pricing to watch. Layla isn't out of it: People wanting oral or injectable semaglutide with a brand-inclusive glp-1 upgrade path.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Found | Layla |
|---|---|---|
| Value Score | 78 (B-) | 74 (C+) |
| Est. first month | $289/mo cash month-to-month · $169/mo on a 12-month prepay | From $199/mo (all doses, compounded) |
| Save vs brand-name | ~93% | ~85% |
| Semaglutide | $289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); the advertised $99 is the in-network INSURANCE rate and still precedes a ~$30 per-visit copay | From $237/mo (all doses, compounded) |
| Tirzepatide | $289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); one program price covers both molecules | From $199/mo (all doses, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Watch | Flat — no step-up |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Found
The widest medication bench in this ranking — compounded, brand-name and oral — priced off a membership whose $99 headline only holds if you commit for months.
Why it's a deal
- Widest medication list here: compounded semaglutide and tirzepatide, brand Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda and Victoza, plus oral Foundayo (orforglipron) and Rybelsus
- Flat pricing as the dose increases — a titration does not raise the monthly cost
- Bills insurance for the clinical visits; the site says most members pay under $30 per visit
- Runs a dedicated GLP-1 microdose program for people who want a lower starting dose
The fine print
- The $99/mo is a longer-plan floor, not a month-to-month rate — Found's own FAQ says its 3, 6 and 12-month plans are what keep the monthly cost down, so paying monthly costs more
- Medication cost is separate from the membership and clinical care, so no advertised figure is the all-in number
- The homepage insurance selector lists roughly 41 states, not 50 — coverage is narrower than the service footprint
- Compounded medication is not FDA-approved the way brand Wegovy or Zepbound are
Layla
Layla is a US telehealth weight-loss program built around semaglutide, offering compounded semaglutide as injections and as oral dropper drops, plus compounded tirzepatide and a brand-inclusive GLP-1…
Why it's a deal
- Oral semaglutide dropper option plus injectable semaglutide and tirzepatide, with a brand-name upgrade path
- Named Medical Director (Dr. Ruth Cohen) and 24-7 doctor messaging
- Quiz-based intake with fast three to five day shipping
The fine print
- Brand-inclusive GLP-1 program is expensive, starting around 1,299 dollars
- States served are not published on the site
- Support phone line uses a UK format, and the compounding pharmacy is not named
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Found is ranked on the Found alternatives ranking, and the same list for the other side is on alternatives to Layla.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.